abstract |
The present invention relates to novel 4-pyrazin-2-ylmethyl-morpholines of formula (A), methods for their preparation, pharmaceutical compositions containing same, and treatment of conditions in therapy, in particular associated with NR2B negative allosteric modulating properties. or to its use in prophylaxis. [Formula A] |